Bioventus Stock In The News

BVS Stock  USD 10.68  0.03  0.28%   
Our overall analysis of Bioventus' news coverage and content from conventional and social sources shows investors' bearish mood towards Bioventus. The specific impact of Bioventus news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bioventus' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bioventus headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bioventus Backtesting and Bioventus Hype Analysis.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Bioventus Today Top News and Investor Outlook

Yahoo News
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
https://finance.yahoo.com/news/bioventus-enters-amendment-credit-agreement-211500697.html
 Bullish
Yahoo News
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
https://finance.yahoo.com/news/bioventus-announces-inducement-equity-president-211500165.html
 Bullish
Yahoo News
Bioventus Names Robert Claypoole as President and Chief Executive Officer
https://finance.yahoo.com/news/bioventus-names-robert-claypoole-president-213000072.html
 Bullish
Yahoo News
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
https://finance.yahoo.com/news/bioventus-agrees-nationwide-contract-aetna-130000257.html
 Bullish
Yahoo News
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript
https://finance.yahoo.com/news/bioventus-inc-nasdaq-bvs-q3-140220032.html
 Bullish
Yahoo News
Bioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial Guidance
https://finance.yahoo.com/news/bioventus-inc-bvs-reports-q3-125926612.html
 Neutral
Macroaxis News: globenewswire.com
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
https://www.globenewswire.com/news-release/2023/11/07/2774904/0/en/Bioventus-Reports-Third-Quarter-Financial-Results-Raises-Full-Year-2023-Financial-Guidance.html
 Neutral
Yahoo News
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
https://finance.yahoo.com/news/bioventus-reports-third-quarter-financial-120000360.html
 Neutral
Macroaxis News: globenewswire.com
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
https://www.globenewswire.com/news-release/2023/10/31/2770012/0/en/Bioventus-to-Report-Third-Quarter-of-Fiscal-Year-2023-Financial-Results-on-November-7-2023.html
 Bullish
Yahoo News
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
https://finance.yahoo.com/news/bioventus-report-third-quarter-fiscal-110000328.html
 Bullish

Bioventus Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bioventus and other traded companies coverage with news coverage. We help investors stay connected with Bioventus headlines for the 1st of February to make an informed investment decision based on correlating the impacts of news items on Bioventus Stock performance. Please note that trading solely based on the Bioventus hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bioventus' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Bioventus investors visualize upcoming and past events in order to time the market based on Bioventus noise-free hype analysis.
Bioventus stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bioventus earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bioventus that are available to investors today. That information is available publicly through Bioventus media outlets and privately through word of mouth or via Bioventus internal channels. However, regardless of the origin, that massive amount of Bioventus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bioventus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bioventus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bioventus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bioventus alpha.

Bioventus Largest EPS Surprises

Earnings surprises can significantly impact Bioventus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-10
2022-03-310.050.04-0.0120 
2021-08-10
2021-06-300.140.160.0214 
2024-11-05
2024-09-300.030.060.03100 
2022-11-08
2022-09-300.120.08-0.0433 
2024-03-12
2023-12-310.020.070.05250 
2021-05-12
2021-03-310.10.150.0550 
View All Earnings Estimates

Bioventus Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bioventus Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
16th of January 2025
Wall Street Analysts Think Bioventus Could Surge 26.03 percent Read This Before Placing a ...
at news.google.com 
fool News
10th of January 2025
This ASX All Ords stock is up 48 percent in under 2 months Why theres more good news to co...
at fool.com.au 
news
8th of January 2025
Three Promising ASX Penny Stocks for Growth Potential in 2025
at kalkinemedia.com 
Gurufocus Stories at Macroaxis
27th of December 2024
Bioventus Inc Trading Down 4.58 percent on Dec 27
at gurufocus.com 
Yahoo News
23rd of December 2024
Disposition of 5848 shares by Dadamio Anthony of Bioventus at 10.53 subject to Rule 16b-3
at finance.yahoo.com 
Google News at Macroaxis
12th of December 2024
Point72 Asset Management L.P. Acquires Shares of 65,974 Bioventus Inc. - MarketBeat
at news.google.com 
fool News
5th of December 2024
Why Bravura, HMC, Magellan, and Perseus shares are pushing higher today
at fool.com.au 
news
4th of December 2024
A Bravura performance Upgraded FY25 guidance and dividend resumption
at finnewsnetwork.com.au 
Google News at Macroaxis
18th of November 2024
Royce Associates LP Invests 8.34 Million in Bioventus Inc. - MarketBeat
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioventus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioventus' short interest history, or implied volatility extrapolated from Bioventus options trading.

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.